Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M T Petrucci

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Annals of Hematology|July 2, 2003
High-dose hydroxyurea in the treatment of poor-risk myeloid leukemiasM C Petti, A Tafuri, R Latagliata, et al.
Leukemia|July 24, 2009
Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myelomaM A Dimopoulos, C Chen, A Spencer, et al.
Experimental Hematology|July 31, 1999
Thrombopoietin and interleukin 11 have different modulatory effects on cell cycle and programmed cell death in primary acute myeloid leukemia cellsA Tafuri, R M Lemoli, M T Petrucci, et al.
Blood|May 1, 1996
Interleukin-9 stimulates the proliferation of human myeloid leukemic cellsR M Lemoli, A Fortuna, A Tafuri, et al.
Blood Cancer Journal|July 26, 2012
Evolution of bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma and Waldenstrom's macroglobulinemia: a retrospective multicentric studyA Andriani, M T Petrucci, T Caravita, et al.
European Journal of Cancer (Oxford, England : 1990)|February 22, 2011
Previous thalidomide therapy may not affect lenalidomide response and outcome in relapse or refractory multiple myeloma patientsT Guglielmelli, S Bringhen, S Rrodhe, et al.
Haematologica|May 9, 2000
Dose-intensive melphalan with stem cell support (CM regimen) is effective and well tolerated in elderly myeloma patientsA Palumbo, S Triolo, L Baldini, et al.
Haematologica|January 12, 2000
Autologous peripheral blood stem cell transplantation as first line treatment of multiple myeloma: an Italian Multicenter StudyM Tribalto, S Amadori, L Cudillo, et al.
Annals of Hematology|February 2, 2021
Daratumumab in multiple myeloma: experience of the multiple myeloma GIMEMA Lazio groupFederico Vozella, A Siniscalchi, M Rizzo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2011
Primary plasma cell leukemia: a retrospective multicenter study of 73 patientsL Pagano, C G Valentini, V De Stefano, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Annals of Hematology|July 2, 2003
High-dose hydroxyurea in the treatment of poor-risk myeloid leukemiasM C Petti, A Tafuri, R Latagliata, et al.
Leukemia|July 24, 2009
Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myelomaM A Dimopoulos, C Chen, A Spencer, et al.
Experimental Hematology|July 31, 1999
Thrombopoietin and interleukin 11 have different modulatory effects on cell cycle and programmed cell death in primary acute myeloid leukemia cellsA Tafuri, R M Lemoli, M T Petrucci, et al.
Blood|May 1, 1996
Interleukin-9 stimulates the proliferation of human myeloid leukemic cellsR M Lemoli, A Fortuna, A Tafuri, et al.
Blood Cancer Journal|July 26, 2012
Evolution of bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma and Waldenstrom's macroglobulinemia: a retrospective multicentric studyA Andriani, M T Petrucci, T Caravita, et al.
European Journal of Cancer (Oxford, England : 1990)|February 22, 2011
Previous thalidomide therapy may not affect lenalidomide response and outcome in relapse or refractory multiple myeloma patientsT Guglielmelli, S Bringhen, S Rrodhe, et al.
Haematologica|May 9, 2000
Dose-intensive melphalan with stem cell support (CM regimen) is effective and well tolerated in elderly myeloma patientsA Palumbo, S Triolo, L Baldini, et al.
Haematologica|January 12, 2000
Autologous peripheral blood stem cell transplantation as first line treatment of multiple myeloma: an Italian Multicenter StudyM Tribalto, S Amadori, L Cudillo, et al.
Annals of Hematology|February 2, 2021
Daratumumab in multiple myeloma: experience of the multiple myeloma GIMEMA Lazio groupFederico Vozella, A Siniscalchi, M Rizzo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2011
Primary plasma cell leukemia: a retrospective multicenter study of 73 patientsL Pagano, C G Valentini, V De Stefano, et al.
Pageof 6